|
Marché Fermé -
Euronext Bruxelles
17:55:00 25/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 4,450 EUR | -3,05% |
|
+5,95% | -34,94% |
| 24/09 | Hyloris Pharmaceuticals SA publie ses résultats pour le semestre clos le 30 juin 2026 | CI |
| 15/07 | Hyloris Pharmaceuticals : accord de licence exclusif pour l'antalgique Maxigesic en Chine | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3,05% | +5,95% | +1,37% | -4,30% | -34,94% | -23,80% | -63,82% | -67,64% | - | 142 M | ||
| +0,13% | +2,65% | -0,50% | -2,04% | +10,12% | +63,34% | +115,17% | +410,82% | +1 388,25% | 1 055 Md | ||
| +0,20% | +0,46% | +0,45% | +6,50% | +31,06% | +50,92% | +70,56% | +65,02% | +130,28% | 654 Md | ||
| -0,29% | +0,14% | +0,55% | +4,34% | +15,69% | +19,82% | +71,75% | +146,89% | +312,58% | 467 Md | ||
| -0,85% | +0,98% | -2,17% | +7,23% | +9,78% | +42,13% | +44,64% | +5,85% | +48,82% | 348 Md | ||
| +0,71% | +4,08% | -5,80% | -5,13% | +9,31% | +21,75% | +28,83% | +55,67% | +53,59% | 275 Md | ||
| +1,23% | +0,42% | +2,60% | -12,33% | -8,98% | +14,11% | +12,43% | +41,91% | +146,17% | 258 Md | ||
| +2,11% | +7,51% | -5,84% | +15,71% | +26,67% | +51,88% | +54,11% | +94,10% | +138,93% | 224 Md | ||
| +0,83% | +0,55% | +1,92% | +18,02% | +22,97% | +34,64% | +99,83% | +112,01% | +87,21% | 187 Md | ||
| 0,00% | -10,14% | -17,04% | -20,43% | -22,21% | -27,40% | -61,08% | -21,17% | +70,83% | 171 Md | ||
| +0,92% | +3,65% | +1,31% | +18,03% | +15,14% | +20,66% | -11,51% | -34,75% | -14,77% | 163 Md | ||
| +0,73% | +3,51% | -3,86% | +7,09% | +16,06% | +36,41% | +49,62% | +186,58% | +495,98% | 133 Md | ||
| +2,21% | -0,32% | -6,97% | +9,28% | +16,54% | +42,48% | +7,38% | +4,37% | +13,30% | 128 Md | ||
| -1,39% | -1,41% | -2,55% | -6,66% | +1,45% | +24,56% | +20,81% | +6,69% | -9,35% | 98,2 Md | ||
| -0,43% | -3,05% | -8,30% | -4,37% | -13,21% | -8,34% | -30,15% | -12,47% | +6,21% | 98,02 Md | ||
| -0,51% | -1,93% | -6,17% | -11,00% | -19,74% | +5,25% | +54,69% | +53,72% | +443,04% | 69,17 Md | ||
| +1,43% | +0,02% | +1,86% | +17,34% | +23,45% | +34,50% | +24,25% | +58,29% | +23,30% | 60,57 Md | ||
| +1,30% | +4,01% | +1,85% | +6,43% | +35,15% | +83,56% | +9,50% | +7,58% | -43,92% | 56 Md | ||
| -2,56% | +0,54% | +5,92% | +29,17% | +36,98% | +95,85% | +282,34% | +346,86% | -23,25% | 45,67 Md | ||
| -1,58% | +2,16% | -4,02% | -7,83% | -24,69% | -35,99% | +0,36% | -9,92% | +175,78% | 44 Md | ||
| Moyenne | +0,06% | +1,09% | -2,27% | +3,25% | +7,33% | +27,32% | +38,98% | +72,52% | +181,21% | 226,76 Md | |
| Moyenne pondérée par Capi. | +0,28% | +1,25% | -1,74% | +2,45% | +12,49% | +37,99% | +59,90% | +144,05% | +424,67% |
- Bourse
- Actions
- Action HYL
- Secteur Hyloris Pharmaceuticals SA
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















